Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.38 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.38 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4147100 | 0.91 | KCNA5 (0.36) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL25685120 | 0.79 | ALDH1A1 (0.35) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL3975457 | 0.79 | ALDH1A1 (0.35) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL24292469 | 0.77 | KCNA5 (0.50) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL7776690 | 0.77 | TSHR (0.47) | KCNA5ALDH1A1TSHRTDP1 | |
| SCHEMBL20753133 | 0.77 | LMNA (0.42) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL7571504 | 0.76 | KCNA5 (0.38) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL25761576 | 0.76 | KCNA5 (0.38) | KCNA5KCNJ5KCNJ3SCN5AKCND3 | |
| SCHEMBL20465406 | 0.71 | TSHR (0.41) | KCNA5TSHR | |
| SCHEMBL2478250 | 0.71 | CYP1A2 (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | KCNA5 4734/4885KCNJ5 4767/4885KCNJ3 4727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.